Philip Scheltens, MD, PhD, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Christopher Randolph, PhD, ABPP-CN, chief scientific officer, WCG MedAvanteProPhase. Dr. Scheltens is professor of cognitive neurology and director of the Alzheimer Center at the VU University Medical Center in Amsterdam.